Par Drugs and Chemicals Limited (PAR.NS)
INR 95.99
(1.31%)
INR 95.99
(1.31%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 529.13 Million INR | 84.43% |
| 2022 | 286.9 Million INR | 17.89% |
| 2021 | 243.36 Million INR | 8.44% |
| 2020 | 224.42 Million INR | 45.08% |
| 2019 | 154.69 Million INR | 18.01% |
| 2018 | 131.08 Million INR | 4.8% |
| 2017 | 125.08 Million INR | 7.79% |
| 2016 | 116.03 Million INR | -43.13% |
| 2015 | 204.03 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 151.19 Million INR | 17.27% |
| 2024 Q2 | 203.3 Million INR | 34.47% |
| 2023 Q2 | 148.63 Million INR | 31.42% |
| 2023 Q1 | 113.1 Million INR | 202.1% |
| 2023 Q3 | 138.47 Million INR | -6.84% |
| 2023 Q4 | 128.92 Million INR | -6.89% |
| 2023 FY | 529.13 Million INR | 84.43% |
| 2022 Q2 | 143.93 Million INR | 13.33% |
| 2022 Q4 | -110.77 Million INR | -187.41% |
| 2022 FY | 286.9 Million INR | 17.89% |
| 2022 Q1 | 127 Million INR | 237.28% |
| 2022 Q3 | 126.73 Million INR | -11.95% |
| 2021 Q1 | 103.82 Million INR | 294.0% |
| 2021 FY | 243.36 Million INR | 8.44% |
| 2021 Q4 | -92.52 Million INR | -188.76% |
| 2021 Q3 | 104.23 Million INR | -18.45% |
| 2021 Q2 | 127.82 Million INR | 23.11% |
| 2020 Q4 | -53.51 Million INR | -152.86% |
| 2020 Q3 | 101.24 Million INR | 14.59% |
| 2020 FY | 224.42 Million INR | 45.08% |
| 2020 Q1 | 88.35 Million INR | 19.78% |
| 2020 Q2 | 88.35 Million INR | 0.0% |
| 2019 Q4 | 73.76 Million INR | 0.0% |
| 2019 FY | 154.69 Million INR | 18.01% |
| 2019 Q3 | 73.76 Million INR | -12.14% |
| 2019 Q2 | 83.95 Million INR | 0.0% |
| 2019 Q1 | 83.95 Million INR | 28.63% |
| 2018 Q4 | 65.26 Million INR | 0.0% |
| 2018 FY | 131.08 Million INR | 4.8% |
| 2018 Q1 | 70.24 Million INR | 0.0% |
| 2018 Q2 | 70.24 Million INR | 0.0% |
| 2018 Q3 | 65.26 Million INR | -7.08% |
| 2017 FY | 125.08 Million INR | 7.79% |
| 2016 FY | 116.03 Million INR | -43.13% |
| 2015 FY | 204.03 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 98.024% |
| Hester Biosciences Limited | 1.27 Billion INR | 58.455% |
| Aarti Drugs Limited | 8.31 Billion INR | 93.637% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 90.926% |
| Albert David Limited | 1.4 Billion INR | 62.422% |
| Alembic Limited | 1 Billion INR | 47.092% |
| Alkem Laboratories Limited | 52.29 Billion INR | 98.988% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -17.026% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 64.049% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -4117.904% |
| Brooks Laboratories Limited | 65.62 Million INR | -706.364% |
| Eris Lifesciences Limited | 10.42 Billion INR | 94.925% |
| FDC Limited | 6.58 Billion INR | 91.966% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 95.744% |
| Gufic Biosciences Limited | 4.07 Billion INR | 87.011% |
| Hikal Limited | 5.95 Billion INR | 91.119% |
| Ind-Swift Limited | 2.17 Billion INR | 75.644% |
| Innova Captab Limited | 3.46 Billion INR | 84.727% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 88.787% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 18.918% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 97.306% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 71.957% |
| Lupin Limited | 125.09 Billion INR | 99.577% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | 23.446% |
| Medico Remedies Limited | 262.14 Million INR | -101.849% |
| Morepen Laboratories Limited | 6.16 Billion INR | 91.412% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 89.03% |
| Orchid Pharma Limited | 2.32 Billion INR | 77.195% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 90.848% |
| RPG Life Sciences Limited | 2.48 Billion INR | 78.69% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | 14.721% |
| Sigachi Industries Limited | 2 Billion INR | 73.573% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 131.955% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 87.167% |
| Themis Medicare Limited | 2.42 Billion INR | 78.135% |
| Unichem Laboratories Limited | 4.86 Billion INR | 89.123% |
| Vaishali Pharma Limited | 90.32 Million INR | -485.826% |
| Wanbury Limited | 1.73 Billion INR | 69.425% |
| Windlas Biotech Limited | 1.33 Billion INR | 60.477% |
| ZIM Laboratories Limited | 1.26 Billion INR | 58.264% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 87.198% |
| Ipca Laboratories Limited | 48.58 Billion INR | 98.911% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.795% |
| Venus Remedies Limited | 2.18 Billion INR | 75.756% |
| Sakar Healthcare Limited | 699.58 Million INR | 24.364% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 99.517% |
| Divi's Laboratories Limited | 32.44 Billion INR | 98.369% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 91.497% |
| Mankind Pharma Limited | 42.19 Billion INR | 98.746% |
| Sequent Scientific Limited | 2.97 Billion INR | 82.236% |
| Laurus Labs Limited | 15.44 Billion INR | 96.575% |
| Neuland Laboratories Limited | 8.24 Billion INR | 93.585% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 96.532% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 99.237% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 99.577% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 74.731% |
| Wockhardt Limited | 7.72 Billion INR | 93.146% |
| Bal Pharma Limited | 770.19 Million INR | 31.298% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.677% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 85.681% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 94.253% |
| Shilpa Medicare Limited | 3.56 Billion INR | 85.145% |
| Valiant Laboratories Limited | 138.02 Million INR | -283.351% |
| Ajanta Pharma Limited | 21.06 Billion INR | 97.488% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -368.142% |
| Granules India Limited | 16.79 Billion INR | 96.85% |
| Medicamen Biotech Limited | 495.49 Million INR | -6.789% |
| Syncom Formulations (India) Limited | 559.5 Million INR | 5.427% |
| Piramal Enterprises Limited | 8.04 Billion INR | 93.421% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 98.868% |
| NATCO Pharma Limited | 25.73 Billion INR | 97.944% |
| Suven Life Sciences Limited | -200.79 Million INR | 363.518% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 586.575% |
| Strides Pharma Science Limited | 14.38 Billion INR | 96.322% |
| Indoco Remedies Limited | 8.04 Billion INR | 93.421% |
| Alpa Laboratories Limited | 188.89 Million INR | -180.122% |
| Lasa Supergenerics Limited | 121.02 Million INR | -337.194% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -35.306% |